Submit Deal

SCHUELKE & MAYR GMBH

Summary

Schulke & Mayr GmbH was founded in 2009. The Company's line of business includes the manufacturing of in vitro and in vivo diagnostic substances.

Deals Overview

Total Deals4

Valued Deals1

Total Value£ 226 M

Avg. Deal Size£ 226 M

Market Context

Subsidiaries

SCHUELKE & MAYR GMBH (PERSONAL CARE BUSINESS)

1 transaction

Senior Management

Christian Last
CEO
Stefan Kukacka
CEO

Sort

jamieson

HQ - London

financial advisors (1)

1 Shared Deal

1 For

n/a

Total Value

baker mckenzie

HQ - Chicago

legal advisors (1)

1 Shared Deal

1 Along

n/a

Total Value

jp morgan

HQ - New York

financial advisors (1)

1 Shared Deal

1 Along

n/a

Total Value

credit agricole

HQ - Paris

debt providers (1)

1 Shared Deal

1 Along

n/a

Total Value

deloitte

HQ - London, United Kingdom

financial advisors (1)

accounting advisors (2)

3 Shared Deals

1 For | 1 Along | 1 Opposite

£ 226 M

Total Value

goldman sachs

HQ - New York, United States

financial advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

freshfields

HQ - London

legal advisors (3)

3 Shared Deals

1 For | 1 Along | 1 Opposite

£ 226 M

Total Value

vinge

HQ - Stockholm

legal advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

hps investment partners

debt providers (1)

1 Shared Deal

1 Opposite

n/a

Total Value

ramboll

HQ - Copenhagen, Denmark

technical advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

clifford chance

HQ - London

legal advisors to debt providers (1)

1 Shared Deal

1 Opposite

n/a

Total Value

kekst cnc

HQ - New York

pr advisors (3)

3 Shared Deals

2 Along | 1 Opposite

£ 226 M

Total Value